What is Nextern?
Nextern, headquartered in St. Paul, MN, with manufacturing operations in China, specializes in creating cGMP-compliant, non-invasive solutions aimed at enhancing personal health, wellness, and safety. Over the past decade, the company has demonstrated a robust product development pipeline, contributing treatments for a range of conditions including depression, low vision, wound care, and respiratory ailments. Their portfolio also extends to automated home treatment systems, robotic solutions for emergency services, and assistive technologies designed to empower individuals with disabilities.
How much funding has Nextern raised?
Nextern has raised a total of $74K across 1 funding round:
Debt
$74K
Debt (2021): $74K with participation from PPP
What's next for Nextern?
The recent capital injection at this significant Series B/C stage signals Nextern's strategic intent to scale its operations and further innovate within the personal health technology sector. This investment will likely fuel advancements in their existing product lines and potentially support the development of new therapeutic and assistive devices. The company's focus on a diverse range of medical needs positions it for continued growth and impact in improving patient outcomes and quality of life.
See full Nextern company page
